Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Brigham Young University et al v. Pfizer et al
Case Number:
2:06-cv-00890
Court:
Nature of Suit:
Judge:
Firms
- Beus Gilbert
- Bryan Cave
- DLA Piper
- Hatch Law Group
- James Dodge
- Kunzler Bean
- Munger Tolles
- Price Parkinson
- Ray Quinney
- Sidley Austin
- Stoel Rives
- Thorpe North
- WilmerHale
- Winston & Strawn
Companies
Sectors & Industries:
-
May 01, 2012
Pfizer Settles BYU's Long-Running Celebrex Suit
Pfizer Inc. said Tuesday that it has settled Brigham Young University's long-running contract and trade secrets lawsuit that claimed one of the school's professors discovered the enzyme behind the development of the drugmaker's anti-inflammatory drugs Bextra and Celebrex.
-
April 16, 2012
Judge Finds No New Misconduct By Pfizer In Celebrex Suit
A Utah federal judge on Monday denied Brigham Young University's move for sanctions in its contract and trade secrets suit against Pfizer Inc. over the anti-inflammatory drugs Bextra and Celebrex, finding there is nothing indicating an attempt by Pfizer to hide or destroy evidence.
-
March 13, 2012
Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
A Utah federal judge on Tuesday declined to rule on two claims in a contract and trade secrets suit brought against Pfizer Inc. by Brigham Young University and a professor who claims he discovered an enzyme that led to the development of the anti-inflammatory drugs Bextra and Celebrex.